1H-Benzimidazole-7-carboxylic acid

Catalog No. :
ACPVWL326
CAS No. :
46006-36-4
Molecular Formula :
C8H6N2O2
Molecular Weight :
162.15

IUPAC Name:1H-benzo[d]imidazole-7-carboxylic acid

1H-Benzimidazole-7-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$87.00Login to see priceIn stockIn stock
25g98%$303.00Login to see priceIn stockIn stock
100g98%$1127.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1H-Benzimidazole-7-carboxylic acid
IUPAC Name1H-benzo[d]imidazole-7-carboxylic acid
MDL No.MFCD01823426 | MFCD11656261
Molecular FormulaC8H6N2O2
Molecular Weight162.15
SMILES[NH]1C2=C(N=C1)C=CC=C2C(=O)O
InChI KeyVVQNAFBGAWCMLU-UHFFFAOYSA-N
Synonymbenzimidazole-7-carboxylic acid | FS-2575 | 7-benzimidazolylcarboxylic acid | CS-D0827 | 1,3-benzimidazole-4-carboxylic acid | AB01334554-02 | W-202814 | 1H-benzimidazole-4-carboxylic acid | 1H-Benzimidazole-4-carboxylic acid, 97% | 1H-BENZO[D]IMIDAZOLE-4
CAS No.46006-36-4
PubChem CID2771758

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H319
Precautionary Statement(s)
P305+P351+P338

Synthetic Route by SureRoute

1. ACPVWL326 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUFIN684 route compound structure diagram
    ACUFIN684603-81-6 In Stock
  2. Plus
  3. ACEDMW612 route compound structure diagram
    ACEDMW6126108-23-2 In Stock
  4. Then
  5. ACPVWL326 route product structure diagram
    ACPVWL32646006-36-4 In Stock
Inquiry

2. ACPVWL326 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIPXY584 route compound structure diagram
    ACIPXY584606-18-8 In Stock
  2. Plus
  3. ACEDMW612 route compound structure diagram
    ACEDMW6126108-23-2 In Stock
  4. Then
  5. ACPVWL326 route product structure diagram
    ACPVWL32646006-36-4 In Stock
Inquiry

Comments (0)